Product Code: ETC5264687 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The dermatology drugs market in Canada is expanding due to an increasing prevalence of skin disorders and heightened awareness of skin health. Innovations in drug formulations and the rise of specialty dermatology clinics contribute to market growth. Despite this, the market faces challenges including high drug development costs and regulatory hurdles.
The dermatology drugs market in Canada benefits from an increasing prevalence of skin disorders and a growing awareness of dermatological health. Advances in drug formulations and the development of new therapies, including biologics and targeted treatments, are key drivers. Additionally, the rising focus on personalized medicine and innovative drug delivery systems supports market expansion.
The dermatology drugs market in Canada faces several hurdles, including high costs associated with research and development of new drugs. Regulatory approval processes can be lengthy and costly, impacting the time-to-market for new products. There is also the challenge of managing competition from generic drug manufacturers and addressing varying levels of insurance coverage for dermatological treatments. Additionally, shifting patient preferences and increasing scrutiny on drug pricing contribute to market challenges.
Regulations governing dermatology drugs in Canada are primarily enforced by Health Canada, which is responsible for the approval and monitoring of pharmaceuticals. The Patented Medicine Prices Review Board (PMPRB) oversees drug pricing to ensure affordability and accessibility. Additionally, the Canadian Dermatology Association (CDA) may influence clinical guidelines and treatment protocols within the dermatology sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Dermatology Drugs Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Dermatology Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Dermatology Drugs Market - Industry Life Cycle |
3.4 Canada Dermatology Drugs Market - Porter's Five Forces |
3.5 Canada Dermatology Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Canada Dermatology Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Canada Dermatology Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Dermatology Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of skin disorders and diseases in Canada |
4.2.2 Growing awareness about skincare and aesthetic treatments |
4.2.3 Technological advancements in dermatology drugs and treatments |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for dermatology drugs |
4.3.2 High cost associated with dermatology drugs and treatments |
4.3.3 Potential side effects and risks of certain dermatology drugs |
5 Canada Dermatology Drugs Market Trends |
6 Canada Dermatology Drugs Market Segmentations |
6.1 Canada Dermatology Drugs Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Canada Dermatology Drugs Market Revenues & Volume, By Acne, 2021-2031F |
6.1.3 Canada Dermatology Drugs Market Revenues & Volume, By Atopic Dermatitis, 2021-2031F |
6.1.4 Canada Dermatology Drugs Market Revenues & Volume, By Psoriasis, 2021-2031F |
6.1.5 Canada Dermatology Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Canada Dermatology Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Canada Dermatology Drugs Market Revenues & Volume, By Oral, 2021-2031F |
6.2.3 Canada Dermatology Drugs Market Revenues & Volume, By Parenteral, 2021-2031F |
6.2.4 Canada Dermatology Drugs Market Revenues & Volume, By Topical, 2021-2031F |
6.3 Canada Dermatology Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Canada Dermatology Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.3.3 Canada Dermatology Drugs Market Revenues & Volume, By Retail Pharmacy, 2021-2031F |
6.3.4 Canada Dermatology Drugs Market Revenues & Volume, By Online Pharmacy, 2021-2031F |
7 Canada Dermatology Drugs Market Import-Export Trade Statistics |
7.1 Canada Dermatology Drugs Market Export to Major Countries |
7.2 Canada Dermatology Drugs Market Imports from Major Countries |
8 Canada Dermatology Drugs Market Key Performance Indicators |
8.1 Number of dermatology clinics and skincare centers in Canada |
8.2 Research and development investment in dermatology drugs |
8.3 Adoption rate of innovative dermatology treatments and technologies |
8.4 Patient satisfaction and outcomes following dermatology drug treatments |
8.5 Percentage of dermatologists offering specialized dermatology drug treatments |
9 Canada Dermatology Drugs Market - Opportunity Assessment |
9.1 Canada Dermatology Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Canada Dermatology Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Canada Dermatology Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Dermatology Drugs Market - Competitive Landscape |
10.1 Canada Dermatology Drugs Market Revenue Share, By Companies, 2024 |
10.2 Canada Dermatology Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |